| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.4M | +85.2% |
| SG&A Expense | $2.0M | +15.4% |
| Operating Income | -$3.4M | -36.8% |
| Interest Expense | $963K | -24.1% |
| Net Income | -$4.4M | -20.6% |
| EPS (Basic) | -$0.97 | -10.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $296K | -60.2% |
| Current Assets | $296K | -60.2% |
| Total Assets | $535K | -39.5% |
| Current Liabilities | $13.5M | +8.6% |
| Total Liabilities | $13.6M | +9.2% |
| Stockholders' Equity | -$13.0M | -13.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | -26.2% |
| Capital Expenditures | $4K | +82.7% |
| Investing Cash Flow | -$4K | -82.7% |
| Financing Cash Flow | $1.8M | -24.3% |
| Free Cash Flow | -$2.3M | -26.2% |